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Abstract
Background: Vasopressin is one of the most important physiological stress and shock hormones. Copeptin, a
stable vasopressin precursor, is a promising sepsis marker in adults. In contrast, its involvement in neonatal diseases
remains unknown. The aim of this study was to establish copeptin concentrations in neonates of different stress
states such as sepsis, chorioamnionitis and asphyxia.
Methods: Copeptin cord blood concentration was determined using the BRAHMS kryptor assay. Neonates with
early-onset sepsis (EOS, n = 30), chorioamnionitis (n = 33) and asphyxia (n = 25) were compared to a control
group of preterm and term (n = 155) neonates.
Results: Median copeptin concentration in cord blood was 36 pmol/l ranging from undetectable to 5498 pmol/l
(IQR 7 - 419). Copeptin cord blood concentrations were non-normally distributed and increased with gestational
age (p < 0.0001). Neonates born after vaginal compared to cesarean delivery had elevated copeptin levels (p <
0.0001). Copeptin correlated strongly with umbilical artery pH (Spearman’s Rho -0.50, p < 0.0001), umbilical artery
base excess (Rho -0.67, p < 0.0001) and with lactate at NICU admission (Rho 0.54, p < 0.0001). No difference was
found when comparing copeptin cord blood concentrations between neonates with EOS and controls
(multivariate p = 0.30). The highest copeptin concentrations were found in neonates with asphyxia (median 993
pmol/l). Receiver-operating-characteristic curve analysis showed that copeptin cord blood concentrations were
strongly associated with asphyxia: the area under the curve resulted at 0.91 (95%-CI 0.87-0.96, p < 0.0001). A cut-off
of 400 pmol/l had a sensitivity of 92% and a specifity of 82% for asphyxia as defined in this study.
Conclusions: Copeptin concentrations were strongly related to factors associated with perinatal stress such as
birth acidosis, asphyxia and vaginal delivery. In contrast, copeptin appears to be unsuitable for the diagnosis of
EOS.
Keywords: asphyxia early-onset sepsis, copeptin, neonate, vasopressin
Background
Arginine vasopressin (or antidiuretic hormone, ADH), is
a nonapeptide acting as a main regulator in the homeos-
tatis of the cardiovascular and renal system [1]. It is pro-
duced by the hypothalamus and secreted in the
posterior lobe of the pituitary gland upon hemodynamic
or osmotic stimuli. Vasopressin plays a crucial role in
the endocrine stress response to a variety of diseases
such as different shock states [2]. Exogenous vasopressin
is a promising therapeutic agent in cardiac arrest and
septic shock in adults [3]. A recent multicenter rando-
mized controlled trial evaluated low-dose vasopressin in
pediatric vasodilatory shock [4]. Although few authors
have reported successful use of vasopressin in neonates
with arterial hypotension [5-8], data on the role of vaso-
pressin during the neonatal period are scarce.
Since vasopressin is highly instable with a short half-
life of 4-20 minutes [1], reliable determination of
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tice. Vasopressin is derived from a larger precursor pep-
tide which contains also C-terminal pro-vasopressin,
called copeptin [9]. Upon release of vasopressin, equal
amounts of copeptin are secreted. Copeptin is relatively
stable in serum and thereby reliably mirrors vasopressin
levels [10,11]. Copeptin concentrations were strongly
elevated in samples from adult patients with sepsis
[9,12,13] and high copeptin levels were predictive of
mortality [12,14]. Recent studies in adults have shown
that copeptin is a valuable biomarker of infection in
patients with community-acquired and ventilator-asso-
ciated pneumonia [14].
Wellmann et al. have recently provided normal values
for healthy term and near-term infants [15], but, to the
best of our knowledge, copeptin has never been investi-
gated in neonates with major diseases. We hypothesized
that copeptin cord blood concentrations in neonates
may be associated with different stress situations such
as sepsis and perinatal asphyxia.
Neonatal infections account for over one million neo-
natal deaths worldwide every year [16]. Early-onset sep-
sis (EOS, presenting within 72 hours of age) occurs in
approximately 0.6% of term and up to 1.5% of preterm
infants and contributes significantly to neonatal mortal-
ity [17]. Therefore, early treatment of neonates with sus-
pected infection is crucial to prevent life threatening
complications. New infection markers may potentially
improve guidance of therapeutic decisions [18].
Perinatal asphxia is, after prematurity and sepsis, the
third main cause of neonatal death worldwide [19].
While therapeutic hypothermia has proven to improve
survival and to reduce the rate of disability, mortality
due to severe perinatal hypoxic-ischemic encephalopathy
remains high even in developed countries [20].
This study therefore aimed to establish copeptin cord
blood concentrations in neonates of different gestational
ages and to assess the influence of sepsis, chorioamnio-
nitis and asphyxia on copeptin concentrations.
Methods
Infants born between November 2004 and November
2007 at the Department of Obstetrics, University of Bern,
Switzerland, were eligible for this study if cord blood
serum had been drawn and stored immediately after
birth. Neonates with major congenital malformations
were excluded. The study was approved by the institu-
tional Ethical Board (Direktion Lehre und Forschung,
Inselspital, University of Bern, 3010 Bern, Switzerland).
Patients and controls were searched using the institu-
tional neonatal database. Perinatal characteristics and
postnatal parameters were extracted from the institu-
tional neonatal database. Arterial umbilical cord pH was
obtained routinely. Blood gasa n a l y s e sa n dh e m o g l o b i n
concentrations were obtained routinely in neonates
admitted to the neonatal intensive care unit (NICU) and
were included in this study if they had been obtained
within six hours after birth. Small for gestational age
(SGA) was defined as infants with a birth weight below
the 10
th percentile. Arterial hypotension was defined as
mean arterial blood pressure which was below the gesta-
tional age limit at two consecutive measurements and
that was treated with either a volume bolus administra-
tion, intravenous corticosteroids or catecholamines.
The following groups were defined: early-onset sepsis
group, chorioamnionitis group, asphyxia group, and
control group.
Early onset sepsis group (EOS)
EOS cases were defined as neonates who presented with
sepsis within the first 72 hours of life as defined by the
following criteria [21]: i) at least two clinical signs of
sepsis (temperature instability, irritability or apathy,
feeding difficulties, poor capillary refill >2 seconds,
apnea, tachycardia and/or tachypnea); ii) elevated C-
reactive protein >20 mg/l, iii) decision of the attending
physician to treat for at least 7 days with intravenous
antibiotics and iv) recovery of bacterial pathogens in
blood-culture. In infants with negative blood cultures
but clinical diagnosis of EOS, all first three criteria men-
tioned above were required to be present.
Chorioamnionitis group
Chorioamnionitis was defined as either clinically diag-
nosed chorioamnionitis (requiring presence of maternal
fever, elevated maternal CRP, fetal tachycardia and pro-
longed rupture of membranes >24 h) or histologically
diagnosed chorioamnionitis [22]. Only infants exposed
to chorioamnionitis without evidence of neonatal infec-
tion as defined above were considered in order to avoid
overlap with the EOS group.
Asphyxia group
Asphyxia was defined according to our institutional
guidelines as arterial cord blood pH below 7.1 plus
10-minute Apgar score below 6 and/or base excess
>-12 mmol/l. This definition allowed to include both
severe asphyxia [20], and milder forms of asphyxia. In
addition, the asphyxia group required absence of clinically
or histologically diagnosed chorioamnionitis and of con-
firmed EOS as defined above in order to avoid overlap
with the EOS and the chorioamnionitis group. Hypoxic-
ischemic encephalopathy (HIE) was graded according to
Sarnat stage 0 (no HIE) to stage 3 (severe HIE) [23].
Control group
Based on sample size calculations, a control group of at
least 135 controls was required to detect a mean
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with a power of 80% at a 95%-confidence interval. The
assumptions were based on preliminary internal data
and on published data from adults with sepsis [24]. The
control group (n = 155) consisted of 75 premature neo-
nates (24 0/7 to 36 6/7 weeks gestational age) without
neonatal infection, chorioamnionitis or asphyxia (as
defined above) and of 80 healthy term neonates (37 0/7
to 42 0/7 weeks gestational age) with no signs of any
neonatal disease. Neonates with major congenital mal-
formations were excluded. The control group infants
were all born between January 2007 and November
2007.
Copeptin measurements
Cord blood is routinely collected immediately after
delivery of the child from the umbilical vein at the pla-
cental side of the cord, and is routinely stored at our
institution to determine Toxoplasma gondii serology in
neonates of mothers with unknown or negative serosta-
tus. After centrifugation, cord blood serum was frozen
in sterile tubes at -80°C. Copeptin cord blood concen-
trations were determined using the commercial
BRAHMS copeptin kryptor assay according to the man-
ufacturer’s instructions (BRAHMS, Hennigsdort, Ger-
many). The detection limit of the assay was 4.8 pmol/l.
Statistical analysis
Copeptin concentrations were compared between
patients and controls using Mann-Whitney U test and
multivariate linear regression analysis. Multivariate ana-
lyses included gestational age, birth weight, SGA, mode
of delivery and umbilical artery pH as covariates. Spear-
man’s rank test and multivariate linear regression were
used to analyze association between copeptin cord
blood concentration with linear variables. Copeptin cord
blood concentrations were logarithmized for regression
analyses. Mann-Whitney U-test was used where appro-
priate. Receiver-operating-characteristic (ROC) curve
analysis was used to assess specifity and sensitivity of
copeptin for the diagnosis of EOS, chorioamnionitis and
asphyxia. Two-sided tests were used throughout, and P-
values below 0.05 were considered significant. SPSS 18.0
software was used.
Results
i) Patient characteristics
During the study period, 3896 neonates were born, 42 of
whom fulfilled the EOS criteria. Cord blood serum was
available in 30 (72%) neonates with EOS, these were
thus included in the study. Their median gestational age
was 31 weeks. In eight (27%) patients, blood cultures
resulted positive. Maximum C-reactive protein during
s e p s i sw a sa tm e d i a n4 4m g / l( r a n g e2 2-2 6 1 ) .F i v e
infants (17%) required treatment with catecholamines
due to septic shock and two (7%) infants died during
sepsis. The chorioamnionitis group comprised 33 neo-
nates without evidence of neonatal infection with a
median gestational age of 30 weeks.
During the study period, 36 neonates were born with
asphyxia. Of these, cord blood serum was available in 25
(69%). Their median gestational age was 37 weeks. Two
(8%) had HIE Sarnat stage 3 and died, three (12%) Sarnat
stage 2, and seven (28%) Sarnat stage 1, while 13 (52%)
had no signs of HIE. Their median lactate concentration
at NICU admission was 10.7 mmol/l (range 4 - 25).
Baseline characteristics of the patient groups and the
control group are given in Table 1.
ii) Copeptin cord blood concentrations in the whole
cohort
When analyzing copeptin cord blood concentrations in
the whole study population (n = 243), median concen-
tration was 36 pmol/l ranging from undetectable to
5498 pmol/l (IQR 7 - 419). Copeptin concentration cor-
related significantly with gestational age (Spearman’s
Rho 0.30, p < 0.0001, Figure 1), and birth weight (Rho
0.29, p < 0.0001), but did not differ between boys and
girls (Mann-Whitney Z -10.98, p = 0.33). Infants after
vaginal delivery compared to cesarean delivery had sig-
nificantly higher copeptin levels (Mann-Whitney Z
-7.32, p < 0.0001, Figure 2), even when adjusting for
gestational age (p < 0.001). Copeptin cord blood con-
centration showed a strong negative correlation with
umbilical artery pH (Rho -0.50, p < 0.0001) and umbili-
cal artery base excess (Rho -0.67, p < 0.0001), see Figure
3. Similarly, copeptin concentration correlated strongly
with pH (Rho -0.34, p < 0.0001) and with lactate at
NICU admission (Rho 0.54, p < 0.0001), see Figure 3.
The correlations between copeptin and pH, base excess
and lactate remained significant in subgroup analyses on
very preterm, late preterm and term neonates (< 32,
32-36 6/7, ≥ 37 weeks gestational age, p < 0.05, details
not shown).
No association was found between copeptin cord
blood concentrations and arterial hypotension requiring
treatment with volume and/or vasopressors, or with
hemoglobin concentration and hematocrit at NICU
admission (p >0.05).
iii) Copeptin cord blood concentrations in neonates with
EOS and with chorioamnionitis
Median copeptin concentrations were 35 pmol/l (IQR 8 -
212) in the EOS versus 20 pmol/l (IQR 6 - 139) in the
chorioamnionitis group versus 21 pmol/l (IQR 5 - 324) in
controls, see Figure 4. Although median copeptin con-
centrations were higher in EOS infants compared to con-
trols, this was not statistically significantly (Mann-
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variate linear regression analysis adjusted for gestational
age, birth weight, SGA, delivery mode and umbilical
artery pH (beta coefficient 0.16, 95%-CI -0.14 - 0.45, p =
0.30), Copeptin concentrations did not significantly differ
between EOS infants with septic shock or with positive
blood cultures compared to the rest of EOS infants
(p >0.05). ROC curve analysis confirmed that the perfor-
mance of copeptin to distinguish EOS from controls was
poor (area under the curve, 0.53, 95%-CI 0.44 - 0.63, p =
0.57). No difference was found when comparing copeptin
levels between the chorioamnionitis group and controls
or between the chorioamnionitis and the EOS group
(p >0.1). Copoeptin was not associated with CRP, leuko-
cyte count or left shift (immature by total neutrophil
ratio, p >0.05, details not shown).
iv) Copeptin cord blood concentrations in neonates with
asphyxia
Copeptin cord blood concentrations were significantly
higher in the 25 neonates with asphyxia (median 993
pmol/l, IQR 505 - 2466, range 100 - 5498) compared to
controls (Mann-Whitney Z -6.49, p < 0.0001), see Figure
5. This was confirmed by multivariate analysis (beta
coefficient 1.09, 95%-CI 0.41 - 1.76, p = 0.002). Notably,
the eight highest copeptin values measured, all above
2000 pmol/l, occurred in neonates with asphyxia. None
of these eight neonates with very high copeptin levels
had more than Sarnat stage one HIE, and all survived.
Copeptin concentration was not significantly correlated
with Sarnat score (Rho -0.31, p = 0.133).
Table 1 Baseline characteristics according to study group
Study group Early-onset sepsis
(N = 30)
Chorioamnionitis
(N = 33)
Asphyxia
(N = 25)
Control
(N = 155)
Gender (male) 12 (40%) 12 (36%) 10 (40%) 87 (56%)
Gestational age [weeks] 31.5 (29-34) 30 (28-34) 36.5 (33-39) 38 (32-40)
Birth weight [gram] 1665 (1161-2490) 1430 (998-1975) 2400 (1573-3213) 2800 (1590-3420)
Prenatal steroids 23 (77%) 27 (82%) 8 (32%) 64 (41%)
Cesarean section 18 (60%) 18 (55%) 17 (68%) 73 (47%)
PROM >24 h 7 (23%) 10 (30%) 2 (8%) 16 (10%)
SGA 3 (10%) 4 (12%) 7 (28%) 11 (7%)
APGAR 1 min 5 (3-7) 6 (4-8) 3 (2-6) 8 (6-8)
APGAR 5 min 8 (6-9) 8 (7-9) 7 (5-8) 9 (8-9)
APGAR 10 min 9 (7-9) 9 (8-9) 8 (7-9) 9 (9-9)
Cord blood arterial pH 7.30 (7.24-7.33) 7.29 (7.24-7.33) 7.03 (7.00-7.07) 7.29 (7.25-7.32)
PDA 6 (20%) 5 (15%) 0 (0%) 11 (7%)
Arterial hypotension 12 (40%) 11 (33%) 11 (44%) 32 (21%)
Mechanical ventilation 16 (53%) 13 (39%) 8 (32%) 13 (8%)
Median (interquartile range) or number (percentage) are shown.
PDA, persistent ductus arteriosus; PROM, prolonged rupture of membranes; SGA, small for gestational age (< 10
th percentile)
Figure 1 Copeptin and gestational age. Copeptin cord blood
concentrations are shown according to gestational age. The dotted
line indicates the detection limit (4.8 pmol/l).
Figure 2 Copeptin concentration is increased after vaginal
delivery. Copeptin cord blood concentrations according to the
delivery mode are shown. The medians and the p-value of Mann-
Whitney U test are shown. The dotted line indicates the detection
limit (4.8 pmol/l).
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tions discriminated with high accuracy between
asphyxia, as defined in this study, and controls: the area
under the curve resulted at 0.91 (95%-CI 0.87 - 0.96, p
< 0.0001, see Figure 6). A cut-off of 400 pmol/l had a
sensitivity of 92% and a specifity of 82%.
Discussion
Our findings indicate that copeptin cord blood concen-
trations reflect perinatal stress with the highest values
found in neonates with asphyxia. To the best of our
Figure 3 Copeptin concentration correlates with perinatal acidosis. Copeptin cord blood concentrations are plotted against umbilical artery
pH (A, n = 236), umbilical artery base excess (B, n = 60), pH at admission to the NICU (C, n = 138) and lactate concentration at admission to
the NICU (D, n = 100). The dotted line indicates the detection limit (4.8 pmol/l).
Figure 4 Copeptin concentration and early-onset sepsis.
Copeptin cord blood concentrations in neonates with early-onset
sepsis (EOS) and chorioamnnionitis compared with controls. The
medians are shown. The dotted line indicates the detection limit
(4.8 pmol/l).
Figure 5 Copeptin concentration in infants with asphyxia.
Copeptin cord blood concentrations in neonates with asphyxia
compared with controls. The medians and the p-value of Man-
Whitney U test are shown. The dotted line indicates the detection
limit (4.8 pmol/l).
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in newborns with EOS and asphyxia.
Copeptin cord blood concentration was strongly and
inversely correlated with umbilical artery pH, umbilical
artery base excess, and with pH and lactate at admission
to the NICU. Perinatal acidosis results from diminished
fetal blood and oxygen supply due to maternal, placental
or cord complications leading to lactic acidosis. Vaso-
pressin is released by the hypothalamus-hypopituitary
upon sensing of increased plasma osmolality, decreased
arterial pressure, and reductions in cardiac volume [1].
Our data indicate that the vasopressin system in the
neonate is strongly activated upon perinatal stress.
Importantly, the strength of these correlations was com-
parable between very preterm, late preterm and term
infants, suggesting that the vasopressin response is
already present at an early gestational age.
The highest copeptin cord blood concentrations were
found in neonates with perinatal asphyxia. This finding
was confirmed by multivariate analysis adjusted for
gestational age, birth weight, mode of delivery and
umbilical artery pH. Most values in this group, a third
of them exceeding 2000 pmol/l, were much higher that
concentrations that have been reported in adult studies
on patients with septic shock, multiple trauma or myo-
cardial infarction [9,25,26]. Copeptin cord blood concen-
trations above 400 pmol/l had a high sensitivity and
specifity for asphyxia. Perinatal asphyxia can be consid-
ered as an extreme of a stress situation. In a study on
the stress response to hypoxia in neonatal piglets, main-
tenance of cardiovascular function and a higher serum
cortisol concentration were associated with a better neu-
rological outcome [27]. Further studies are needed to
determine whether copeptin is related to asphyxia sever-
ity and whether copeptin may improve outcome prog-
nostication after asphyxia.
Neonates born by vaginal delivery had significantly
elevated copeptin cord blood concentrations compared
to those born by cesarean section, even after adjustment
for gestational age. Wellmann et al. have recently deter-
mined copeptin in 177 neonates and found higher levels
after vaginal delivery as well [15]. These findings are in
line with earlier reports of elevations in the stress hor-
mone cortisol after vaginal delivery [28]. Spontaneous
labour physiologically induces important changes in the
fetal homeostatic system which serve to prime the fetus
for postnatal adaptation.
Copeptin has been shown to be a valuable infection
marker in adults with sepsis and community-acquired
pneumonia [9,12-14]. In contrast, in our study, copeptin
concentrations in cord blood were not significantly ele-
vated in EOS infants compared to controls. The specifity
and sensitivity of copeptin in the diagnosis of EOS was
poor. Similarly, no difference was found between neo-
nates born to mothers with chorioamnionitis and con-
trols. Given the strong influence of perinatal stress on
copeptin cord blood concentrations, and considering the
very large interindividual variations observed in this
study, our data indicate that determining copeptin con-
centrations is not suitable to diagnose EOS. Potentially,
the diagnostic accuracy of copeptin may be improved in
late-onset infections, since the effect of perinatal stress
on copeptin disappears over the first days of life [15].
Several limitations of this study need to be mentioned.
Firstly, only neonates where cord blood was available
were included. A selection bias is, however, unlikely,
since cord blood was routinely collected during the
study period in neonates of mothers with unknown or
negative Toxoplasma gondii serostatus, a condition
which is unlikely to affect copeptin cord blood concen-
trations. Secondly, the relatively small sample sizes lim-
its statistical power. Therefore, confirmation by future
prospective cohorts is needed.
We believe that the present study has several strengths.
In contrast to the study by Wellmann et al. [15] which
included only healthy term and near term infants, we
included neonates with a wide range of gestational ages.
The inclusion of clearly defined and not overlapping
groups of infants with EOS, chorioamnionitis and
asphyxia allowed to study the influence of these diseases
on copeptin concentration. Multivariate analyses were
adjusted for the main confounders gestational age, birth
weight, delivery mode and umbilical artery pH.
Figure 6 Receiver-operating-characteristic curve of copeptin
concentrations in relation to asphyxia. Receiver-operating-
characteristic curve is shown for copeptin cord blood
concentrations in relation to asphyxia. The dotted lines indicate the
optimal discriminative cut-off of 400 pmol/l, resulting in a sensitivity
of 92% and a specifity of 82%.
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We report that copeptin concentrations in cord blood
are strongly correlated to perinatal stress with the high-
est values found in neonates with perinatal asphyxia.
Future studies should prospectively determine copeptin
concentrations in combination with novel markers of
neonatal brain damage, such as neuron-specific enolase
or S-100B [29-31], in order to investigate whether
copeptin concentrations are of prognostic value during
asphyxia.
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